Medical Science Manager
Sobi
Medical Science Manager
Sobi
Develops therapies for rare diseases
Under the guidance of the MSMs Lead Poland, the Medical Science Manager (MSM) drives the implementation of the Country medical affairs plans related primarily to KOL engagement, scientific data generation support and data dissemination.
KOL Engagement:
Data Dissemination:
Medical leadership and strategic planning
Knowledge, expertise and insights management
We are seeking a self-driven, scientifically credible professional with a relevant university degree and experience in medical communication, KOL engagement, pre-launch and launch activities, and cross-functional project leadership.
You will combine therapeutic-area expertise with a sound understanding of healthcare systems, patient access, and the regulatory and compliance environment. Strong scientific presentation, stakeholder-management, strategic-thinking and prioritisation skills are essential, together with fluency in English, high personal integrity and a clear commitment to Sobi values. The role requires flexibility, independent working and frequent domestic travel (approximately 40%), including occasional meetings outside standard working hours.
Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:
Sobi is a global company with over 2000 employees in more than 30 countries and are committed to the societies where we operate. We are a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases, providing reliable access to innovative medicines in the areas of haematology, immunology, and specialty care. Sobi’s share is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
We know our employees are our most valuable asset and our culture conveys that. We offer a competitive benefits package, to support the health and happiness of our staff.
Sobi Culture
At Sobi, we refuse to accept the status quo. This is because we have witnessed first-hand the challenges facing those affected by rare diseases and have used this knowledge to shape our business to find new ways of helping them.
As a specialized biopharmaceutical company, we are dedicated to rare diseases. And we see this focus as a strength. By effectively turning our research into ground-breaking treatments, we help make medicine more accessible and open more possibilities for patients and more opportunities for those caring for them. This has been our approach since day one, but we know we can’t change the world of rare diseases on our own. Accomplishing this requires strong partnerships with patients, partners and stakeholders across the entire value chain. Together, we define how our business can create solutions that serve the needs of those affected by rare diseases while facilitating sustainable growth.
Sobi specializes in developing and delivering therapies for rare diseases. It focuses on hematology, immunology, and specialty care, bringing medicines to patients who have limited treatment options. Their products are designed to treat rare conditions and are typically administered by prescription under medical supervision; the company collaborates with partners to advance research, develop, and commercialize these therapies. Sobi differentiates itself through its strong biotechnological foundation from its Biovitrum heritage and a track record of strategic collaborations with major pharmaceutical players like Sanofi and Apellis, which expand its research capabilities and reach. The company’s goal is to improve the lives of patients with rare diseases worldwide by creating and delivering effective treatments that address unmet medical needs.
Explore more opportunities at Sobi